Haleon Announces PDMR Share Transactions in Compliance with UK Regulations

An announcement from Haleon PLC Sponsored ADR ( (HLN) ) is now available.

On April 11, 2025, Haleon plc announced a notification in compliance with the UK Market Abuse Regulation regarding transactions by Persons Discharging Managerial Responsibilities (PDMRs). The announcement detailed the acquisition of partnership shares and the award of matching shares under the company’s Share Reward Plan by Adrian Morris, General Counsel, and Tamara Rogers, Chief Marketing Officer, on April 9, 2025. This disclosure is significant for stakeholders as it reflects the company’s commitment to transparency and regulatory compliance, potentially impacting investor confidence and market perceptions.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.

Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon plc is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company’s product portfolio includes five major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals and Supplements (VMS). Haleon’s well-known brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum are rooted in trusted science, innovation, and a deep understanding of human needs.

YTD Price Performance: 2.01%

Average Trading Volume: 11,401,954

Technical Sentiment Signal: Sell

Current Market Cap: $42B

Learn more about HLN stock on TipRanks’ Stock Analysis page.